Accordingly, we identified tumor infiltration by CD66b+ TANs in the stroma to be a robust poor prognostic biomarker for UCB patients, representing an additional example of clinically relevant interaction between stomal cells in the tumor microenvironment. This evidence concerns the gene CEACAM8 and neoplasm.